Please login to the form below

Not currently logged in
Email:
Password:

Cancer Research UK's Karen Vousden to join BMS board

She will also serve on the pharma firm's Science and Technology Committee

Cancer Research UK's Karen Vousden is set to join Bristol-Myers Squibb’s board of directors in January.

Vousden is currently chief scientist at Cancer Research UK, as well as serving as group leader at the Francis Crick Institute in London, will also sit the pharma firm's Science and Technology Committee.

She has more than 30 years experience in cancer research and her previous roles have included director of the Beatson Institute for Cancer Research and leadership positions at the US National Cancer Institute.

Giovanni Caforio, BMS’ chairman and chief executive officer, said: "Karen is a world class cancer researcher and a highly accomplished leader in her field.

“Her understanding of cancer biology and immunology research will bring valuable insights to advancing our strategy and strong pipeline in oncology along with our broader pipeline of transformational medicines.”

18th September 2017

From: Research

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Iguazu

Iguazu Ltd is a digital healthcare agency, delivering tactical and innovative solutions. WHAT WE DO We are Closed Loop Marketing...

Latest intelligence

Numbers, navigation, and narratives: digital storytelling in medical communications
Science and storytelling aren’t often seen as compatible. One is based on cold, hard facts, while the other is synonymous with improvisation and theater. However, when done well, storytelling can...
Is this common data mistake killing your digital patient recruitment?
Without realising, you could be falling into the trap of using social data — insights into recent, relevant trends and topics — to inspire your content. Hold up. That sounds...
Stick or Twist? Healthcare brands in a (post) COVID-19 world
...